David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 576 - 600 of 679

  1. Vlahov D, Brookmeyer RS. The evaluation of needle exchange programs. Am J Public Health. 1994 Dec; 84(12):1889-91.
  2. McMillian T, Dorsey E, Beilenson P, Vlahov D. A community-based Needle Clean-Up Project. Am J Public Health. 1994 Nov; 84(11):1854.
  3. Kendig N, Stough T, Austin P, Kummer L, Swetz A, Vlahov D. Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Rep. 1994 Nov-Dec; 109(6):756-60.
  4. Gershon RR, Curbow B, Kelen G, Celantano D, Lears K, Vlahov D. Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers. Am J Infect Control. 1994 Oct; 22(5):293-9.
  5. Celentano DD, Muñoz A, Cohn S, Nelson KE, Vlahov D. Drug-related behavior change for HIV transmission among American injection drug users. Addiction. 1994 Oct; 89(10):1309-17.
  6. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994 Oct; 24(4):1025-32.
  7. Schütz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994 Oct; 36(2):129-38.
  8. Chilcoat HD, Muñoz A, Vlahov D, Anthony JC. Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty. Drug Alcohol Depend. 1994 Aug; 36(1):39-48.
  9. Aylward RB, Vlahov D, Muñoz A, Rapiti E. Validation of the proposed World Health Organization staging system for disease and infection in a cohort of intravenous drug users. AIDS. 1994 Aug; 8(8):1129-33.
  10. Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users. J Acquir Immune Defic Syndr (1988). 1994 Jul; 7(7):760-6.
  11. Gleghorn AA, Doherty MC, Vlahov D, Celentano DD, Jones TS. Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr (1988). 1994 Jul; 7(7):767-72.
  12. Vlahov D, Muñoz A, Solomon L, Astemborski J, Lindsay A, Anderson J, Galai N, Nelson KE. Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS. 1994 Jun; 8(6):819-23.
  13. Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. Am J Public Health. 1994 Jun; 84(6):920-3.
  14. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994 Jun; 22(3):415-30.
  15. Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D. The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sex Transm Dis. 1994 May-Jun; 21(3):161-7.
  16. Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994 May 01; 139(9):918-26.
  17. Margolick JB, Muñoz A, Vlahov D, Astemborski J, Solomon L, He XY, Nelson KE, Saah AJ. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch Intern Med. 1994 Apr 25; 154(8):869-75.
  18. Beekmann SE, Vlahov D, Koziol DE, McShalley ED, Schmitt JM, Henderson DK. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin Infect Dis. 1994 Apr; 18(4):562-9.
  19. Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, Lelli V, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS. 1994 Mar; 8(3):345-50.
  20. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 1994 Mar; 84(3):382-7.
  21. Vlahov D, Ryan C, Solomon L, Cohn S, Holt MR, Akhter MN. A pilot syringe exchange program in Washington, DC. Am J Public Health. 1994 Feb; 84(2):303-4.
  22. Schütz CG, Vlahov D, Anthony JC, Graham NM. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol. 1994 Feb; 47(2):191-5.
  23. Vlahov D. HIV seroconversion studies among intravenous drug users. AIDS. 1994 Feb; 8(2):263-5.
  24. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev. 1994; 16(2):418-36.
  25. Vlahov D. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S3-6.